<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Severe <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> is a rare but severe complication of <z:e sem="disease" ids="C0040156" disease_type="Disease or Syndrome" abbrv="">thyrotoxicosis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In this report, we describe four patients with <z:e sem="disease" ids="C0018213" disease_type="Disease or Syndrome" abbrv="">Graves' disease</z:e> who presented with <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> at diagnosis </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="50673">Methimazole</z:chebi> (30-40 mg/d) or <z:chebi fb="0" ids="8502">propylthiouracil</z:chebi> (400 mg/d) restored <z:mpath ids='MPATH_458'>normal</z:mpath> hematopoiesis in three of the patients </plain></SENT>
<SENT sid="3" pm="."><plain>The remaining patient evolved to <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> under therapy with <z:chebi fb="0" ids="50673">methimazole</z:chebi> (60 mg/d), but had an increased peripheral blood count that almost reached <z:mpath ids='MPATH_458'>normal</z:mpath> values after radioiodinetherapy and standard immunosuppressive treatment with antithymocyte globulin (700 mg/d, intravenous infusion for 5 days), oral cyclosporin (400 mg/d), <z:chebi fb="0" ids="8382">prednisone</z:chebi> (30-60 mg/d), and granulocyte colony-stimulating factor (150 microg subcutaneous injection, 3 times per week) </plain></SENT>
<SENT sid="4" pm="."><plain>We conclude that: (1) a hematologic evaluation of <z:hpo ids='HP_0000001'>all</z:hpo> patients with <z:e sem="disease" ids="C0018213" disease_type="Disease or Syndrome" abbrv="">Graves' disease</z:e> should be performed before administering <z:chebi fb="0" ids="50671">antithyroid drugs</z:chebi>, (2) <z:chebi fb="0" ids="50671">antithyroid drugs</z:chebi> may be administered to patients with <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> and bone marrow hypercellularity but a reevaluation of the bone marrow must be done if there is no recovery of the peripheral blood cell count when euthyroidism state is achieved, (3) standard immunosuppressive treatment of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> caused by <z:chebi fb="0" ids="50671">antithyroid drugs</z:chebi> restores <z:mpath ids='MPATH_458'>normal</z:mpath> hematopoiesis, and (4) a thyroid evaluation of patients with <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> should be done, even though no related symptoms are found </plain></SENT>
</text></document>